Stephen MacMahon AO's Publications

About Stephen MacMahon AO's Publications

Founding Director, The George Institute for Global Health
  • Professor of Cardiovascular Medicine, Faculty of Medicine, UNSW Sydney
  • Chair of Global Health, Faculty of Medicine, Imperial College of London

  • Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial

    Kidney International Date published:

  • APOE genotype, ethnicity, and the risk of cerebral hemorrhage

    Neurology Date published:

  • High prevalence of chronic kidney disease in Thailand

    Kidney International Date published:

  • INDEPENDENT IMPACT OF ALBUMINURIA AND KIDNEY FUNCTION ON CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE TRIAL

    Date published:

  • RENOPROTECTION WITH PERINDOPRIL-INDAPAMIDE BELOW CURRENT RECOMMENDED BLOOD PRESSURE TARGETS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: RESULTS OF THE ADVANCE TRIAL

    Date published:

  • Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: Results of the ADVANCE trial

    Date published:

  • Intensive glucose control in type 2 diabetes - Reply

    New England Journal of Medicine Date published:

  • Dr. Patel and colleagues reply

    New England Journal of Medicine Date published:

  • The ADVANCE trial - Authors' reply

    The Lancet Date published:

  • Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis

    The Lancet Date published:

  • The Burden of Blood Pressure-Related Disease

    Hypertension Date published:

  • Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths

    The Lancet Date published:

  • 2007 Paul Dudley White International Lecture-Global Inequalities in Cardiovascular Healthcare-Our Greatest Challenge

    Circulation Date published:

  • Chronic Kidney Disease, Cardiovascular Events, and the Effects of Perindopril-Based Blood Pressure Lowering: Data from the PROGRESS Study

    Journal of the American Society of Nephrology Date published:

  • Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

    The Lancet Date published:

  • COMPARISON OF THE ASSOCIATIONS BETWEEN HAEMOSTATIC AND INFLAMMATORY VARIABLES AND CHD RISK: FLETCHER CHALLENGE STUDY

    Journal of Thrombosis and Haemostasis Date published: